Skip to content

The ROS1ders

Bridging ROS1 Patients TO RESEARCH

Menu
  • ABOUT ROS1
    • Drugs to Treat ROS1+ Cancer
    • Clinical Trials for ROS1+ Patients
    • ROS1 Experts
  • BLOG
  • PROJECTS
    • The ROS1 Cancer Model Project
  • RESOURCES
  • ABOUT US
  • CONTACT US

Tag: RXDX-101

Holy rash almighty


Holy rash almighty. Below is a graphic image for mature audiences only. Consider yourself warned. …continue reading…

Posted on August 2, 2015September 16, 2015Author lillytninCategories Corey WoodTags clinical trial, Entrectinib, RXDX-101, Side effects

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 1,158 other followers

Tags

advocacy ASCO18 brain metastasis cancer models clinical trial Clinical trials community crizotinib diagnosis education Entrectinib G2032R IASLC Webinar Lung cancer Lung Cancer Canada Lungenkrebs mechanisms of resistance Newsletters NICE patient-driven research research results ROS1 ROS1 Cancer ROS1 testing RXDX-101 Side effects support survey survivorship testing guidelines The ROS1ders TPX-0005 UK Xalkori

ROS1 Cancer Research Forum on Facebook

ROS1 Cancer Research Forum on Facebook

ROS1 Social Media

  • View ROS1 Cancer Research Forum’s profile on Facebook
  • View @ros1cancer’s profile on Twitter

Blog Stats

  • 89,413 hits
Blog at WordPress.com.
  • ROS1 Cancer Facebook Group
  • @ros1 on twitter
  • ROS1 on LinkedIn